Basic Information
Avextra is a cannabis pharmaceutical manufacturer. Founded in 2019, the company focuses on producing precisely formulated cannabis-based medications. Avextra controls the entire value chain – from cultivation in Portugal to EU-GMP certified extraction and manufacturing in Germany. Avextra operates across the European continent through an extensive distribution network of multi-channel and assets strategically developed for these key markets.